SCHEMBL1479353

SCHEMBL1479353

CC=NC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL27691887 0.91 ACHE (0.41)
SCHEMBL20111149 0.74
SCHEMBL27298911 0.74
SCHEMBL9803648 0.74 KDM4E (0.31)
Benzene SCHEMBL27356379 0.73
SCHEMBL3745262 0.71
Methane SCHEMBL28032954 0.71
SCHEMBL15031667 0.71
SCHEMBL16508398 0.71
SCHEMBL25121440 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110093060-A With the coating composite with modified poly- (alkylidene oxide-carbamate) association thickener of hydrophobic oligomers 陶氏环球技术有限责任公司 2019-08-06 CN claimed
US-20140057335-A1 CULTURE MEDIUM FOR CELL GROWTH AND TRANSFECTION Life Technologies Corporation (US) 2014-02-27 US claimed
EP-2351827-A1 Culture medium for cell growth and transfection Life Technologies Corporation (US) 2011-08-03 EP claimed
US-20080286868-A1 METAL BINDING COMPOUNDS AND THEIR USE IN CELL CULTURE MEDIUM COMPOSITIONS INVITROGEN CORPORATION (US) 2008-11-20 US claimed
US-20070254358-A1 Culture medium for cell growth and transfection INVITROGEN CORPORATION (US) 2007-11-01 US claimed
CN-1684641-A Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device ENDOVASCULAR DEVICES INC (US) 2005-10-19 CN claimed
EP-1385933-A4 CULTURE MEDIUM FOR CELL GROWTH AND TRANSFECTION INVITROGEN CORP (US) 2004-05-19 EP claimed
EP-1385933-A1 CULTURE MEDIUM FOR CELL GROWTH AND TRANSFECTION INVITROGEN CORPORATION (US) 2004-02-04 EP claimed
US-20030096414-A1 Culture medium for cell growth and transfection INVITROGEN CORPORATION 2003-05-22 US claimed
WO-2002077202-A1 CULTURE MEDIUM FOR CELL GROWTH AND TRANSFECTION INVITROGEN CORPORATION (US) 2002-10-03 WO claimed
EP-1210410-A2 METAL BINDING COMPOUNDS AND THEIR USE IN CELL CULTURE MEDIUM COMPOSITIONS INVITROGEN CORPORATION (US) 2002-06-05 EP claimed
WO-2001016294-A2 METAL BINDING COMPOUNDS AND THEIR USE IN CELL CULTURE MEDIUM COMPOSITIONS INVITROGEN CORPORATION (US) 2001-03-08 WO claimed
EP-0120092-B1 FOAM FIRE-EXTINGUISHING COMPOSITION NEW JAPAN CHEMICAL CO.,LTD. (JP) 1987-04-08 EP claimed
US-20230130038-A1 SYSTEM AND METHOD FOR HIGH-YIELD TRANSIENT EXPRESSION IN MAMMALIAN CELLS Life Technologies Corporation 2023-04-27 US disclosed
EP-4148122-A1 HIGH YIELD TRANSIENT EXPRESSION IN MAMMALIAN CELLS USING UNIQUE PAIRING OF HIGH DENSITY GROWTH AND TRANSFECTION MEDIUM AND EXPRESSION ENHANCERS Life Technologies Corporation (US) 2023-03-15 EP disclosed
EP-3404095-B1 HIGH YIELD TRANSIENT EXPRESSION IN MAMMALIAN CELLS USING UNIQUE PAIRING OF HIGH DENSITY GROWTH AND TRANSFECTION MEDIUM AND EXPRESSION ENHANCERS LIFE TECHNOLOGIES CORP (US) 2022-07-27 EP disclosed
EP-1210410-A2 METAL BINDING COMPOUNDS AND THEIR USE IN CELL CULTURE MEDIUM COMPOSITIONS INVITROGEN CORPORATION (US) 2002-06-05 EP disclosed
WO-2001016294-A2 METAL BINDING COMPOUNDS AND THEIR USE IN CELL CULTURE MEDIUM COMPOSITIONS INVITROGEN CORPORATION (US) 2001-03-08 WO disclosed
CN-1036399-C Tripeptide antithrombotic agents LILLY CO ELI (US) 1997-11-12 CN disclosed
CN-1060472-A TRIPEPTIDE ANTITHROMBOTIC AGENTS LILLY CO ELI (US) 1992-04-22 CN disclosed